Daisuke Sakamoto - Uzabase Bus Officer
| UBAZFDelisted Stock | USD 11.05 0.00 0.00% |
Insider
Daisuke Sakamoto is Bus Officer of Uzabase
| Phone | 81 3 4533 1999 |
| Web | https://www.uzabase.com |
Uzabase Management Efficiency
Uzabase's management efficiency ratios could be used to measure how well Uzabase manages its routine affairs as well as how well it operates its assets and liabilities.Uzabase has accumulated 2.69 B in total debt with debt to equity ratio (D/E) of 0.42, which is about average as compared to similar companies. Uzabase has a current ratio of 1.65, which is within standard range for the sector. Debt can assist Uzabase until it has trouble settling it off, either with new capital or with free cash flow. So, Uzabase's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Uzabase sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Uzabase to invest in growth at high rates of return. When we think about Uzabase's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Liean MS | Acumen Pharmaceuticals | N/A | |
| Joshua Allen | Chimerix | N/A | |
| Ben Verhaert | Anheuser Busch Inbev | 41 | |
| Nelson Jamel | Anheuser Busch Inbev | 52 | |
| Patrick MBA | Mink Therapeutics | N/A | |
| Roberto Motta | Anheuser Busch Inbev | 64 | |
| Eric MD | Acumen Pharmaceuticals | 69 | |
| Leonard JD | Tarsus Pharmaceuticals | 48 | |
| Bobak MD | Tarsus Pharmaceuticals | N/A | |
| Karen Harrigan | Ardelyx | N/A | |
| Kevin Feehan | Anheuser Busch Inbev | N/A | |
| Dan Pavicich | Ardelyx | N/A | |
| Dianne MSW | Tarsus Pharmaceuticals | 47 | |
| Katherine Barrett | Anheuser Busch Inbev | 51 | |
| Kimia Keshtbod | Ardelyx | N/A | |
| David CPA | Chimerix | 46 | |
| Michael Ackermann | Tarsus Pharmaceuticals | 42 | |
| CPA MST | Ardelyx | 50 | |
| David Nakasone | Tarsus Pharmaceuticals | N/A | |
| Shaun Fullalove | Anheuser Busch Inbev | N/A | |
| Robert Blanks | Ardelyx | 64 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0085 |
Uzabase Leadership Team
Elected by the shareholders, the Uzabase's board of directors comprises two types of representatives: Uzabase inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Uzabase. The board's role is to monitor Uzabase's management team and ensure that shareholders' interests are well served. Uzabase's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Uzabase's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Soshi Kawaguchi, Bus Officer | ||
| Daisuke Chiba, Corp CFO | ||
| Yusuke Inagaki, President Co-CEO, Representative Director | ||
| Yumi Murakashi, Corp Culture | ||
| Seiji Harikae, Corp Management | ||
| Tomoyuki Ota, Corp Devel | ||
| Daisuke Sakamoto, Bus Officer | ||
| Shinobu Matsui, Chief Director | ||
| Taira Sakuma, Executive Officer | ||
| Ayaka Takeda, Bus Officer |
Uzabase Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Uzabase a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0085 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 379.05 M | |||
| Shares Outstanding | 37.97 M | |||
| Shares Owned By Insiders | 100.00 % | |||
| Shares Owned By Institutions | 3.83 % | |||
| Price To Earning | 433.00 X | |||
| Price To Book | 7.49 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Uzabase Pink Sheet
If you are still planning to invest in Uzabase check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Uzabase's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |